Study finds high number of persistent COVID-19 infections in the general population
New study finds that persistent COVID-19 infections are surprisingly common, with around one to three in every 100 infections lasting a month or longer
New study finds that persistent COVID-19 infections are surprisingly common, with around one to three in every 100 infections lasting a month or longer
Erasmus University Medical Center uses ENPICOM’s IGX Platform and services to advance their research on identifying cancer nanobodies
Companies unite in shared vision of enabling researchers to translate genomic insights
Experts at the University of Nottingham have discovered how to create different colors of blue cheese
Researchers from Imperial College London have shown that a blood test can pinpoint the underlying cause of brain injury in newborns
New study findings from the University of Manchester are important for the development of new wound therapies
AI-based algorithm aims to enable cytotechnologists and pathologists to efficiently identify evidence of cervical cancer and precancerous lesions, using AI-based digital cervical system for pap testing.
Strategic partnership harnesses respective organ-specific expertise to provide complete human-derived organ-on-a-chip solution for more accurate in vitro ADME predictions
The collaboration aims to impact the evolution and enhancement of immunoassay solutions in India
License agreement provides StemSight access to CRISPR/Cas9 technology to be applied in the development of cell therapies for corneal blindness
Scientists from the University of Nottingham are one step closer to understanding how bacteria, such as E. coli and Salmonella enterica, share genetic material which makes them resistant to antibiotics
Scitara announces an agreement with Waters Corporation to bring greater lab connectivity
A recent study has revealed the effectiveness of COVID-19 vaccines in preventing long COVID
Researchers explore the challenges of scaling and combining quantum devices (qubits) for applications like climate modeling
The new assay allows for the quantitative measurement of Tau phosphorylated
The collaboration aims to utilize high-quality reagent materials, develop new parameters, and advance technologies in the future
Test could allow clinicians to screen for individuals at high risk of developing the disease and facilitate the introduction of precision therapies that are at clinical trial stage
Expanding biocatalyst solutions will reduce energy use and waste in pharmaceutical and agrochemical industries
Innovation provides United States with first workflow update in 25 years